Component stock Rigel Pharmaceuticals rose by 33.37%, Veracyte rose by 27.46%, Day One Biopharmaceuticals rose by 25.21%, Fortrea Holdings rose by 23.20%, and Sarepta Therapeutics rose by 15.25%. uniQure NV fell by 14.39%, Neurogene fell by 14.75%, Larimar Therapeutics Inc. fell by 15.26%, Compass Pathways fell by 17.19%, Supernus Pharmaceuticals fell by 17.35%, and LENZ Therapeutics fell by 23.46%
The Nasdaq Biotechnology Index closed up more than 1.4%, outperforming the major U.S. stock indices
LongbridgeAI
